Prof. Jim Walsh
Professor Walsh is one of Ireland’s most experienced diagnostics entrepreneurs and now holds the post of Bio-Innovator in Residence with Dublin City University. He is currently executive director and CSO of Trinity Biotech Plc, (NASDAQ: TRIB) an Irish Diagnostics company and executive chairman of Biosensia Ltd., an Irish Point of Care Diagnostics Company. He is also an investor in and director of a number of early stage Diagnostic companies, including Enzolve Technologies Ltd. (Paediatric testing), Epona Biotech (Animal Haematology), Crescent Diagnostics Ltd., (Bone Health).
technology and life science business sectors